Please login to the form below

Not currently logged in
Email:
Password:

Mission Therapeutics

This page shows the latest Mission Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Biomedical Catalyst funding 'must continue', says BIA

Biomedical Catalyst funding 'must continue', says BIA

macular degeneration (AMD), almost £3m for a Kings College London research team developing a T cell therapy for Crohn's disease and £1.9m for Cambridge start-up MISSION Therapeutics to

Latest news

  • Janssen launches EMEA division to market hepatitis C drug

    Janssen launches EMEA division to market hepatitis C drug. Janssen Therapeutics EMEA will be based in Beerse, Belgium. ... Janssen Therapeutics EMEA is on a mission to bring new options to successfully treat patients with this devastating disease.”.

  • GSK forms alliance with Epizyme

    The therapeutics would work by controlling the pathways of gene expression that contribute to diseases. ... Dr Robert Gould, CEO and president of Epizyme, said: "Epizyme's mission is to develop personalised therapeutics for genetically-defined patients

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Dr Colin Goddard appointed chairman at Mission Therapeutics Dr Colin Goddard appointed chairman at Mission Therapeutics

    Dr Colin Goddard appointed chairman at Mission Therapeutics. Will take up the role at the Cambridge, UK firm in January. ... Mission Therapeutics has appointed Dr Colin Goddard as its non-executive chairman, a role he will take up on January 1.

  • Crescendo Biologics appoints CFO Crescendo Biologics appoints CFO

    She joins from PsiOxus Therapeutics where she served as chief financial officer, and has also held a number of positions at Cytomyx Holdings, OrthoMimetics, and Mission Therapeutics. ... ambitious plans to create a high value pipeline of differentiated

  • Mission Therapeutics appoints new chief financial officer Mission Therapeutics appoints new chief financial officer

    Mission Therapeutics appoints new chief financial officer. David Luther joins with 25 years healthcare and pharmaceutical experience. ... Cambridge, UK-based Mission Therapeutics has appointed David Luther as chief financial officer.

  • MISSION appoints Paul Wallace as chief business officer MISSION appoints Paul Wallace as chief business officer

    MISSION appoints Paul Wallace as chief business officer. Joins from Medivir where he was executive VP and head of business development. ... Cancer biotech MISSION Therapeutics has named Paul Wallace as chief business officer.

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics